LyGenesis published new research showing new options for ectopic liver regeneration
Longevity Technology - 25-Jan-2022Could lead to alternative to whole-organ liver transplantation
Join the club for FREE to access the whole archive and other member benefits.
Scientific Founder of LyGenesis and Associate Professor at the University of Pittsburgh.
Dr. Eric Lagasse is an Associate Professor in the Department of Pathology, University of Pittsburgh, with a secondary appointment in Pitt’s Clinical and Translational Institute. Dr. Lagasse is also the Director of the Cancer Stem Cell Center at the McGowan Institute. In 1985, he received his Diplôme d'Etat de Docteur en Pharmacie from University of Strasbourg, France, and in 1989 he completed his PhD in Microbiology from the University of Basel, Switzerland. From 1989 to 1997, Dr. Lagasse completed his post-doctoral work with Dr. Irving Weissman in the Department of Developmental Biology and Pathology, Stanford University. Dr. Lagasse served as the Director, Liver Stem Cell Discovery Program at StemCells Inc, Palo Alto, California, from 1997 until he joined the McGowan Institute in 2004. Dr. Lagasse is also a founder of LyGenesis, an organ regeneration company enabling a patient's own lymph nodes to be used as bioreactors to regrow functioning ectopic organs.
Visit website: http://mirmresearch.net/lagasse/
See also: LyGenesis - Organ regeneration using a patient's lymph nodes as bioreactors to grow ectopic organs
Details last updated 26-Nov-2020
Could lead to alternative to whole-organ liver transplantation